Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis

被引:40
|
作者
Kim, Su-Hyun [1 ]
Kwak, Kichang [3 ]
Jeong, In Hye [1 ]
Hyun, Jae-Won [1 ]
Jo, Hyo-Jin [1 ]
Joung, AeRan [1 ]
Yu, Eun-Seung [2 ]
Kim, Ji-Hee [1 ]
Lee, Sang Hyun [4 ]
Yun, Sooin [5 ]
Joo, Jungnam [5 ]
Lee, Dong-kyun [3 ]
Lee, Jong-Min [3 ]
Kim, Ho Jin [1 ]
机构
[1] Natl Canc Ctr, Res Inst & Hosp, Dept Neurol, 323 Ilsan St, Goyang Si 410769, Gyeonggi Do, South Korea
[2] Natl Canc Ctr, Mental Hlth Clin, Res Inst & Hosp, Goyang Si, South Korea
[3] Hanyang Univ, Dept Biomed Engn, Seoul, South Korea
[4] Natl Canc Ctr, Dept Radiol, Res Inst & Hosp, Goyang Si, South Korea
[5] Natl Canc Ctr, Biometr Res Branch, Res Inst & Hosp, Goyang Si, South Korea
基金
新加坡国家研究基金会;
关键词
Neuromyelitis optica; cognitive aspects; multiple sclerosis; BRAIN ABNORMALITIES; GREY-MATTER; ATROPHY; PATTERNS; MEMORY;
D O I
10.1177/1352458516636246
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To compare the frequency and pattern of cognitive impairment (CI) between patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS). Methods: A total of 82 NMOSD patients, 58 MS patients, and 45 healthy controls (HCs) underwent a neuropsychological assessment. Results: CI was observed in 29% of NMOSD and 50% of MS patients (p<0.001); CI was considered present if a patient scored lower than the fifth percentile compared with HCs in at least three domains. A lower frequency of CI was consistently found when CI was indicated by at least two failed tests (p<0.001). MS patients performed worse than did NMOSD patients on verbal learning and verbal and visual memory tests. Levels of education and depression and the interval from disease onset to treatment were associated with a negative influence on cognition in patients with NMOSD. Conclusion: CI in patients with NMOSD may be not as common as in patients with MS. MS patients exhibited severe impairment, particularly on learning and memory tests, compared with NMOSD patients. Differential prevalence and patterns of CI between NMOSD and MS patients suggest that the two diseases have different mechanisms of brain injury.
引用
收藏
页码:1850 / 1858
页数:9
相关论文
共 50 条
  • [21] Quantitative radiomic biomarkers for discrimination between neuromyelitis optica spectrum disorder and multiple sclerosis
    Huang, D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 923 - 923
  • [22] Comparison of Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis
    Hyun, Jae-Won
    Jang, Hyunmin
    Yu, JaeBin
    Park, Na Young
    Kim, Su-Hyun
    Huh, So-Young
    Kim, Woojun
    Park, Min Su
    Oh, Jeeyoung
    Park, Kee Duk
    Kim, Ho Jin
    JOURNAL OF CLINICAL NEUROLOGY, 2020, 16 (01): : 124 - 130
  • [23] Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
    Kim, Woojun
    Kim, Ho Jin
    JOURNAL OF CLINICAL NEUROLOGY, 2020, 16 (03): : 355 - 368
  • [24] Efficacy and Safety of Rituximab in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
    Ongphichetmetha, Tatchaporn
    Jitprapaikulsan, Jiraporn
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (09) : NP3 - NP4
  • [25] Quantitative Susceptibility Mapping in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
    Kim, W.
    Lee, J. E.
    Lee, K. S.
    Nam, Y.
    Jang, J.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 438 - 438
  • [26] Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder
    Tatchaporn Ongphichetmetha
    Jiraporn Jitprapaikulsan
    Sasitorn Siritho
    Natthapon Rattanathamsakul
    Thammachet Detweeratham
    Naraporn Prayoonwiwat
    Scientific Reports, 14
  • [27] Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach
    Ota, Miho
    Sato, Noriko
    Okamoto, Tomoko
    Noda, Takamasa
    Araki, Manabu
    Yamamura, Takashi
    Kunugi, Hiroshi
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2015, 4 (06) : 515 - 520
  • [28] Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorder
    Uzawa, A.
    Mori, M.
    Masuda, H.
    Ohtani, R.
    Uchida, T.
    Aoki, R.
    Kuwabara, S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2020, 202 (02): : 239 - 248
  • [29] Comparison of neuropathic pain in neuromyelitis optica spectrum disorder and multiple sclerosis
    Hyun, J. -W.
    Jang, H.
    Yu, J.
    Park, N. Y.
    Kim, S. -H.
    Huh, S. -Y.
    Kim, W.
    Park, M. S.
    Oh, J.
    Park, K. D.
    Kim, H. J.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 401 - 402
  • [30] Prevalences and incidences of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea
    Kim, Jee-Eun
    Park, Sang-hyun
    Han, Kyungdo
    Kim, Ho-Jin
    Shin, Dong-wook
    Kim, Sung-Min
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP44 - NP44